News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Oosthuizen Johannes Jacobus
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/05/2023 |
4
| Oosthuizen Johannes Jacobus (President, U.S. Market) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 907 shares
@ $118.22, valued at
$107.2k
Paid exercise price by delivering 447 shares
@ $118.22, valued at
$52.8k
Exercised 907 restricted stock units
@ $0 |
|
| 05/04/2023 |
4
| Oosthuizen Johannes Jacobus (President, U.S. Market) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 20,747 options to buy
@ $117.89, valued at
$2.4M
|
|
| 01/25/2023 |
4
| Oosthuizen Johannes Jacobus (President, U.S. Market) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 2,091 shares
@ $109.88, valued at
$229.8k
|
|
| 11/07/2022 |
4
| Oosthuizen Johannes Jacobus (President, U.S. Market) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 14,703 shares
@ $0
Exercised 17,455 shares
@ $0
Exercised 13,540 shares
@ $0
Exercised 7,045 shares
@ $0
Sold 45,561 shares
@ $99.4706, valued at
$4.5M
Exercised 14,703 options to buy
@ $62.07, valued at
$912.6k
Exercised 17,455 options to buy
@ $77.62, valued at
$1.4M
Exercised 13,540 options to buy
@ $75.36, valued at
$1M
Exercised 7,045 options to buy
@ $73.73, valued at
$519.4k
|
|
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Oosthuizen Johannes Jacobus (SVP, U.S. Market) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 773 shares
@ $87.65, valued at
$67.8k
Paid exercise price by delivering 381 shares
@ $87.65, valued at
$33.4k
Exercised 773 restricted stock units
@ $0 |
|
| 05/03/2022 |
4
| Oosthuizen Johannes Jacobus (SVP, U.S. Market) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 866 shares
@ $88.69, valued at
$76.8k
Paid exercise price by delivering 427 shares
@ $88.69, valued at
$37.9k
Exercised 866 restricted stock units
@ $0 |
|
| 03/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|